No results were found for the filter!
BSA-alpha-Eleostearate Polyunsaturated Fatty Acid Complex...
Item number: Cay43935-5
BSA-alpha-eleostearate polyunsaturated fatty acid complex (1 mM) is composed of alpha-eleostearic acid (alpha-ESA), also known as 9(Z),11(E),13(E)-octadecatrienoic acid (Cay10008349), and bovine serum albumin (BSA) at an approximately 6:1 molar ratio of alpha-eleostearate:BSA. It can be used for efficient fatty acid...
| Keywords: | Bovine Serum Albumin-alpha-Eleostearic Acid, Bovine Serum Albumin-alpha-ESA, BSA:9(Z),11(E),13(E)-Octadecatrienoic Acid,... |
| Application: | Fatty acid substrate, cell culture |
246.00€
*
BSA Control for BSA-Fatty Acid Complexes (10 mM)
Item number: Cay44217-5
BSA control for BSA-fatty acid complexes (10 mM) is a fatty acid-free preparation of BSA intended for use as a control for BSA-fatty acid complexes containing 10 mM fatty acid (Cay44156). It can be used as a control for experiments using BSA-fatty acid complexes to deliver fatty acids to cells in culture for the...
| Application: | 10 mM BSA-fatty acid complex control |
73.00€
*
BSA-Eicosapentaenoate Polyunsaturated Fatty Acid Complex...
Item number: Cay43473-5
A fatty acid substrate, can be used for efficient fatty acid delivery to cells in culture for monitoring fatty acid oxidation or similar processes in various cellular metabolic studies
| Keywords: | Bovine Serum Albumin-Eicosapentaenoate, Bovine Serum Albumin-EPA, BSA-EPA |
| Application: | Fatty acid substrate, cell culture |
246.00€
*
Withania somnifera (Ashwagandha) Aqueous Methanol Extract
Item number: Cay43251-1
A natural extract, contains a crude mixture of bioactive natural products extracted from W. somnifera
| Application: | Natural extract, bioactive compounds |
75.00€
*
Saturated/Monounsaturated Fatty Acid MaxSpec(R) LC-MS...
Item number: Cay17942-1
This mixture contains various saturated or unsaturated fatty acids. The mixture is supplied in an amber ampule in which the headspace has been purged with argon to prevent lipid oxidation. This product has been designed for direct use in LC-MS applications. The solution may be serially diluted for preparation of...
| Application: | LC/MS |
96.00€
*
BSA-Arachidonate Polyunsaturated Fatty Acid Complex (1 mM)
Item number: Cay34931-5
BSA-Arachidonate polyunsaturated fatty acid complex is composed of arachidonic acid (Cay-10006607) and bovine serum albumin (BSA) at an approximately 6:1 molar ratio of arachidonate:BSA. BSA-Arachidonate complexes can be used for efficient fatty acid delivery to cells in culture for the purpose of monitoring fatty...
| Application: | Fatty acid substrate, cell culture |
246.00€
*
Polyunsaturated Fatty Acid MaxSpec(R) LC-MS Mixture
Item number: Cay17941-1
This mixture contains various polyunsaturated fatty acids, including many important essential fatty acids. The mixture is supplied in an amber ampule in which the headspace has been purged with argon to prevent lipid oxidation. This product has been designed for direct use in LC-MS applications. The solution may be...
| Application: | LC/MS |
186.00€
*
Palmitic Acid ethyl ester
Item number: Cay10008202-5
Palmitic acid ethyl ester is a neutral, lipid-soluble form of the free acid. It is one of the fatty acid ethyl esters that increase cytosolic Ca2+ concentration leading to pancreatic acinar cell injury due to excessive consumption of ethanol.{14120}. Formulation: A solution in ethanol. InChI:...
| Keywords: | Ethyl hexadecanoate, Ethyl palmitate, SFE 18:0, hexadecanoic acid, ethyl ester |
| Application: | Bioactive lipid assays |
| CAS | 628-97-7 |
| MW: | 284.5 D |
From 49.00€
*
Pranlukast
Item number: Cay10008319-1
Pranlukast is an orally bioavailable cysteinyl leukotriene 1 (CysLT1) receptor antagonist (IC50s = 4.3-7.2 nM in radioligand binding assays). It is selective for the CysLT1 receptor over the CysLT2 receptor (IC50 = 3,620 nM for the human receptor). Pranlukast inhibits mucus secretion induced by leukotriene D4 (LTD4,...
| Keywords: | ONO-1078, ONO-RS-411, N-[4-oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl]-4-(4-phenylbutoxy)-benzamide |
| Application: | CysLT1 receptor antagonist |
| CAS | 103177-37-3 |
| MW: | 481.5 D |
1,186.00€
*
CP-LC-1422
Item number: Cay41923-10
Lipid CP-LC-1422 is an ionizable cationic amino lipid derived from homocysteine, a naturally occurring amino acid. This lipid has demonstrated an efficient delivery and high protein expression of different kinds of RNA (mRNA, cRNA and saRNA) in vivo. Moreover, using a typical LNP formulation (IL/Ch/DOPE/PEG:...
| Application: | Ionizable cationic amino lipid, homocysteine derivative |
| MW: | 976.53 D |
From 221.00€
*
4-O10b1
Item number: Cay40603-10
An ionizable cationic lipid (pKa = 5.148), LNPs containing 4-O10b1, conjugated to an anti-F4/80 antibody, and encapsulating siRNA targeting the mRNA encoding Tak1 inhibit poly(I:C)-induced production of IL-1beta, IL-6, and TNF-alpha in RAW 264.7 macrophages, intranasal administration of these LNPs decreases lung...
| Keywords: | tetra(decan-2-yl) 3,3',3'',3'''-((piperazine-1,4-diylbis(propane-3,1-diyl))bis(azanetriyl))tetrapropionate |
| Application: | Ionizable cationic lipid, LNP formation |
| MW: | 1049.7 D |
From 112.00€
*
1,2-Dierucoyl-sn-glycero-3-PE
Item number: Cay41090-10
A phospholipid, has been used in the generation of LNPs for the delivery of mRNA in vivo, has been used in the synthesis of various PEG-conjugates for incorporation into liposomes, LNPs containing 1,2-dierucoyl-sn-glycero-3-PE and encapsulating mRNA encoding hEPO increase serum hEPO levels in mice. Formulation: A...
| Keywords: | 1,2-Didocosenoyl-sn-glycero-3-Phosphoethanolamine, 22:1/22:1-PE, di22:1-PE, PE(22:1/22:1), (13Z,13'Z)-13-docosenoic acid,... |
| Application: | Phospholipid, LNP formation |
| CAS | 904304-57-0 |
| MW: | 856.3 D |
From 53.00€
*